Mexiletine Hydrochloride (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Mexiletine Hydrochloride drug offered from Teva Pharmaceuticals USA, Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Mexiletine Hydrochloride |
SUBSTANCE NAME: | MEXILETINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antiarrhythmic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1995-06-05 |
END MARKETING DATE: | 0000-00-00 |
Mexiletine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Mexiletine Hydrochloride from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 1995-06-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-8739_cd40cb9d-9cb1-4117-82e1-7c4eda399e8f |
PRODUCT NDC: | 0093-8739 |
APPLICATION NUMBER: | ANDA074377 |
Other MEXILETINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: